MedPath

Development and validation of prediction models for treatment failure of HFNC in COVID-19: a multicenter cohort study

Not Applicable
Conditions
COVID-19
Registration Number
JPRN-UMIN000050024
Lead Sponsor
Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Patients under 18 years of age Patients who used non-invasive positive pressure ventilation (NIV) prior to the use of HFNT Patients with Do not Intubation Use after extubation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Failure of treatment (intubation or death within 1 week, transition to noninvasive positive pressure ventilation)
Secondary Outcome Measures
NameTimeMethod
Death within 1 week, intubation within 1 week, transition to noninvasive positive pressure ventilation, and Clinicallyy important intubation
© Copyright 2025. All Rights Reserved by MedPath